Patentiflorin A
Patentiflorin A is a potent, broadspectrum HIV-1 inhibitor. Patentiflorin A also inhibits HIV drug-resistant strains.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 857050-63-6
- Formule: C27H26O11
- Masse moléculaire:526.49
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
|
HIV-1 |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HCT-116 | IC50 |
0.012 μM
Compound: 3, patentiflorin A
|
Cytotoxicity against human HCT116 cells
Cytotoxicity against human HCT116 cells
|
[PMID: 15921419] |
| HCT-116 | IC50 |
0.99 μM
Compound: 2
|
Cytotoxicity against human HCT116 cells after 72 hrs by sulforhodamine B and MTT assay
Cytotoxicity against human HCT116 cells after 72 hrs by sulforhodamine B and MTT assay
|
[PMID: 22119124] |
| HEK293 | CC50 |
>80 μM
Compound: Patentiflorin A
|
Cytotoxicity against HEK293 cells incubated for 72 hrs by MTT assay
Cytotoxicity against HEK293 cells incubated for 72 hrs by MTT assay
|
[PMID: 38875806] |
| K562 | IC50 |
1.43 μM
Compound: 2
|
Cytotoxicity against human K562 cells after 72 hrs by sulforhodamine B and MTT assay
Cytotoxicity against human K562 cells after 72 hrs by sulforhodamine B and MTT assay
|
[PMID: 22119124] |
| K562 | IC50 |
16.14 μM
Compound: 2
|
Cytotoxicity against adriamycin-selected multi drug-resistant human K562 cells after 72 hrs by sulforhodamine B and MTT assay
Cytotoxicity against adriamycin-selected multi drug-resistant human K562 cells after 72 hrs by sulforhodamine B and MTT assay
|
[PMID: 22119124] |
| KB | IC50 |
0.004 μM
Compound: 3, patentiflorin A
|
Cytotoxicity against human KB cells
Cytotoxicity against human KB cells
|
[PMID: 15921419] |
| KB | IC50 |
0.093 μM
Compound: 2
|
Cytotoxicity against human KB cells after 72 hrs by sulforhodamine B and MTT assay
Cytotoxicity against human KB cells after 72 hrs by sulforhodamine B and MTT assay
|
[PMID: 22119124] |
| KB | IC50 |
0.573 μM
Compound: 2
|
Cytotoxicity against vincristine-selected multi drug-resistant human KB cells after 72 hrs by sulforhodamine B and MTT assay
Cytotoxicity against vincristine-selected multi drug-resistant human KB cells after 72 hrs by sulforhodamine B and MTT assay
|
[PMID: 22119124] |
| MCF7 | IC50 |
0.003 μM
Compound: 3, patentiflorin A
|
Cytotoxicity against doxorubicin-sensitive human MCF7 cells
Cytotoxicity against doxorubicin-sensitive human MCF7 cells
|
[PMID: 15921419] |
| MCF7 | IC50 |
0.04 μM
Compound: 3, patentiflorin A
|
Cytotoxicity against doxorubicin-resistant human MCF7 cells
Cytotoxicity against doxorubicin-resistant human MCF7 cells
|
[PMID: 15921419] |
| MCF7 | IC50 |
0.44 μM
Compound: 2
|
Cytotoxicity against human MCF7 cells after 72 hrs by sulforhodamine B and MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by sulforhodamine B and MTT assay
|
[PMID: 22119124] |
| PBMC | CC50 |
75 μM
Compound: 1, Natural
|
Cytotoxicity against human PBMC after 48 hrs by CellTiter 96 AQueous one solution cell proliferation assay
Cytotoxicity against human PBMC after 48 hrs by CellTiter 96 AQueous one solution cell proliferation assay
|
[PMID: 28613071] |
Patentiflorin A shows inhibition activity with IC50 values of 32, 31, 30, 32, 108, 61 and 47 nM against Bal: M-Tropic, 89.6: Dual-Tropic, SF162: M-Tropic, Lav.04: T-Tropic, HIV-1LAV, HIV-11617-1 and HIV-1N119, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 857050-63-6
-
Masse moléculaire 526.49
-
Formule C27H26O11
-
SMILES
O=C1C2=C(C3=CC=C(OCO4)C4=C3)C5=CC(OC)=C(OC)C=C5C(O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C)O)O)O)=C2CO1
-
Structure Classification
-
Initial Source
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)